Overview

Clinical Trial to Evaluate the Efficacy and Safety of CKD-391

Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
A Multicenter, Randomized, Double-blind, Active-controlled, Parallel group, Factorial Design, Phase III Clinical Trial.
Phase:
Phase 3
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
Atorvastatin
Atorvastatin Calcium
Ezetimibe